Ligand Pharmaceuticals
LGND
$172.40
Share price
-1.15%
Change (1 day)
55.35%
Change (1 year)
Ligand Pharmaceuticals (LGND) - P/B ratio
P/B ratio as of March 2025 : 2.54
According to Ligand Pharmaceuticals's latest financial reports the company has a price-to-book ratio of 12.6126.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Ligand Pharmaceuticals - P/B ratio (from 2001 to 2024)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2024-12-31 | 2.45 | 38.05% |
| 2023-12-31 | 1.78 | -5.93% |
| 2022-12-31 | 1.89 | -39.92% |
| 2021-12-31 | 3.14 | 39.46% |
| 2020-12-31 | 2.25 | -1.43% |
| 2019-12-31 | 2.29 | -54.48% |
| 2018-12-31 | 5.02 | -27.23% |
| 2017-12-31 | 6.90 | 20.55% |
| 2016-12-31 | 5.73 | -26.69% |
| 2015-12-31 | 7.81 | -81.7% |
| 2014-12-31 | 42.7 | 96.65% |
| 2013-12-31 | 21.7 | 30.23% |
| 2012-12-31 | 16.7 | -41.6% |
| 2011-12-31 | 28.5 | -179.5% |
| 2010-12-31 | -35.9 | -153.08% |
| 2009-12-31 | 67.6 | -369.41% |
| 2008-12-31 | -25.1 | -260.47% |
| 2007-12-31 | 15.6 | -60.73% |
| 2006-12-31 | 39.8 | -639.8% |
| 2005-12-31 | -7.38 | -34.58% |
| 2004-12-31 | -11.3 | -60.61% |
| 2003-12-31 | -28.6 | -652.3% |
| 2002-12-31 | 5.18 |
P/B ratio for similar companies or competitors
| Company | P/B ratio | P/B ratio differencediff. | Country |
|---|---|---|---|
 | 28.6 | 1,026.29% | 🇺🇸 USA |
 | 7.89 | 210.70% | 🇺🇸 USA |
 | 4.88 | 92.28% | 🇬🇧 UK |
 | 5.11 | 101.38% | 🇺🇸 USA |
 | 1.67 | -34.07% | 🇺🇸 USA |
 | 53.0 | 1,986.46% | 🇺🇸 USA |
 | 7.52 | 196.26% | 🇺🇸 USA |
 | 2.41 | -4.95% | 🇺🇸 USA |
 | 5.49 | 116.34% | 🇺🇸 USA |